HCV

Is this a viable division?

 

It may be viable, but the entire HCV marketplace is also very volatile.

 

Nothing is safe from Riads Jihad.

 

Not anymore, lowest paid of all specialty reps, and the only ones that can sell.

 

What do you mean?

 

Volatile? It's worth billions you idiot!!!!

 

Why should any of the Hiv hcv reps stay? lots of secrets, lies, back stabbing, no future opportunities, too much incompetence to successfully launch -start interviewing if you get a better opportunity seriously consider leaving for better stability and better successes. Lipped management only cares about themselves their stock and have lost all the people with knowledge and relationships - merck is making this division primary care RUN

Calling on hospitals, specialists, mid levels, VAs etc we are less valued than oncology reps who make 20 calls a year and don't sell they service. Last time we launched selling oncology and hep c our market share tanked. The only think merck cares about is keeping the $ in Hiv and isn't thiniing about launch this hep c drug with motivate reps. They've knocked the entire division down and keep kicking everyone lower. Hope you're happy Riad Todd Adam etc

 

For other companies...not for Mother Merck!